Journal
JOURNAL OF PSYCHOPHARMACOLOGY
Volume 17, Issue 2, Pages 149-173Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/0269881103017002003
Keywords
anticonvulsants; antidepressants; antipsychotics; bipolar disorder; CBT; depression; evidence-based guidelines; lithium; mania; mood stabilizers; treatment
Ask authors/readers for more resources
The British Association for Psychopharmacology guidelines specify the scope and target of treatment for bipolar disorder. They are based explicitly on the available evidence and presented, similar to previous Clinical Practice guidelines, as recommendations to aid clinical decision-making for practitioners. They may also serve as a source of information for patients and carers. The recommendations are presented together with a more detailed review of the available evidence. A consensus meeting, involving experts in bipolar disorder and its treatment, reviewed key areas and considered the strength of evidence and clinical implications. The guidelines were drawn up after extensive feedback from participants and interested parties. The strength of supporting evidence was rated. The guidelines cover the diagnosis of bipolar disorder, clinical management and strategies for the use of medicines in short-term treatment of episodes, relapse prevention and stopping treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available